Press Resease

Plasma Protein Therapeutic Market - Global Industry Analysis

Plasma Protein Therapeutic Market by Product Type (Coagulation Factors, Immunoglobulin, Alpha-1 Proteinase Inhibitor, and Albumin), by Application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, and Other Indications), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 03-Sep-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3310 Status : Published

Global plasma protein therapeutic market expected to generate revenue of around USD 31.72 billion by end of 2024, growing at a CAGR of around 7.33% between 2018 and 2024. Plasma can be defined as a clear, straw-colored fluid part of the blood which residue after red platelets, blood cells, white blood cells and other cellular components are eliminated.

Description

The report covers forecast and analysis for the Plasma Protein Therapeutic Market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the Plasma Protein Therapeutic Market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Plasma Protein Therapeutic Market on a global level.

In order to give the users of this report a comprehensive view of the Plasma Protein Therapeutic Market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses product type, application segmentation, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Plasma Protein Therapeutic Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the Plasma Protein Therapeutic Market by segmenting the market based on product type, applications, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Based on product type, Plasma Protein Therapeutic Market has been segmented into coagulation factors, immunoglobulin, alpha-1 proteinase inhibitor, and albumin. Based on applications, Plasma Protein Therapeutic Market has been segmented into hemophilia, primary immunodeficiency disorder, idiopathic thrombocytopenic purpura, secondary immunodeficiency, hereditary angioedema, and other indications.

The growing usage of the plasma proteins derived medicines is a major driver of the market growth during the forecast period. Additionally, the introduction of new plasma-derived therapies are the major factors which drive the patient segment in Plasma Protein Therapeutic Market with the highest CAGR during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further divided into major countries including the U.S., Germany, France, the U.K., China, Japan, India, and Brazil. This segmentation includes demand for Plasma Protein Therapeutic Market based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Octapharma, CSL limited, Baxter, Telecris, Grifols, Kedrion, and Chengdu Inst. Japan Red Cross, LFB Group, Shanghai Blood Institute, BPL Group, and Sanquin are some of the nonprofit organizations that are also playing a vital role in Plasma Protein Therapeutic Market market.

This report segments the global Plasma Protein Therapeutic Market as follows:

Global Plasma Protein Therapeutic Market: By Product Type

  • Coagulation factors
  • Immunoglobulin
  • Alpha-1 proteinase inhibitor
  • Albumin

Global Plasma Protein Therapeutic Market: By Applications

  • Hemophilia
  • Primary immunodeficiency disorder
  • Idiopathic thrombocytopenic purpura
  • Secondary immunodeficiency
  • Hereditary angioedema
  • Other indications

Global Plasma Protein Therapeutic Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Plasma Protein Therapeutic Market, 2015 - 2024 (USD Billion)
    • 2.2. Global Plasma Protein Therapeutic Market: Snapshot
  •  
  • Chapter 3. Plasma Protein Therapeutic Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Plasma Protein Therapeutic Market drivers: Impact analysis
      • 3.2.2. Increasing usage of the plasma proteins derived medicines
      • 3.2.3. Introduction of new plasma-derived therapies
    • 3.3. Market Restraints
      • 3.3.1. Implementation of stringent regulatory policies
      • 3.3.2. Issues pertaining to reimbursements
    • 3.4. Opportunities
      • 3.4.1. Increase in demand for plasma-derived treatments, rise in medical tourism, and increase in disposable income
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Product Type
      • 3.6.2. Market attractiveness analysis, by Application
      • 3.6.3. Market attractiveness analysis, by Regional Segment
  •  
  • Chapter 4. Global Plasma Protein Therapeutic Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Plasma Protein Therapeutic Market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Plasma Protein Therapeutic Market - Product Type Segment Analysis
    • 5.1. Global Plasma Protein Therapeutic Market: Product Type overview
      • 5.1.1. Global Plasma Protein Therapeutic Market revenue share, by Product Type, 2015 and 2024(USD Billion)
    • 5.2. Coagulation Factors
      • 5.2.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 5.3. Immunoglobulin
      • 5.3.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 5.4. Alpha-1 Proteinase Inhibitor
      • 5.4.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 5.5. Albumin
      • 5.5.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
  •  
  • Chapter 6. Global Plasma Protein Therapeutic Market - Application Segment Analysis
    • 6.1. Global Plasma Protein Therapeutic Market: Application overview
      • 6.1.1. Global Plasma Protein Therapeutic Market revenue share, by Application, 2015 and 2024(USD Billion)
    • 6.2. Hemophilia
      • 6.2.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 6.3. Primary immunodeficiency disorder
      • 6.3.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 6.4. Idiopathic Thrombocytopenic Purpura
      • 6.4.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 6.5. Secondary immunodeficiency
      • 6.5.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 6.6. Hereditary Angioedema
      • 6.6.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 6.7. Other indications
      • 6.7.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
  •  
  • Chapter 7. Global Plasma Protein Therapeutic Market - Regional Segment Analysis
    • 7.1. Global Plasma Protein Therapeutic Market: Regional overview
      • 7.1.1. Global Plasma Protein Therapeutic Market revenue share, by Region, 2015 and 2024
    • 7.2. North America
      • 7.2.1. North America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 7.2.2. North America Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
      • 7.2.3. North America Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.2.4.2. The U.S. Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.2.4.3. The U.S. Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.2.5.2. Rest of North America Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.2.5.3. Rest of North America Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 7.3.2. Europe Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
      • 7.3.3. Europe Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.3.4.2. Germany Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.3.4.3. Germany Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.5. U.K.
        • 7.3.5.1. U.K. Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.3.5.2. U.K. Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.3.5.3. U.K. Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.6. France
        • 7.3.6.1. France Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.3.6.2. France Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.3.6.3. France Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.3.7.2. Rest of Europe Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.3.7.3. Rest of Europe Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 7.4.2. Asia Pacific Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
      • 7.4.3. Asia Pacific Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.4.4. China
        • 7.4.4.1. China Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.4.4.2. China Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.4.4.3. China Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.4.5.2. Japan Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.4.5.3. Japan Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.4.6. India
        • 7.4.6.1. India Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.4.6.2. India Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.4.6.3. India Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.4.7.2. Rest of Asia Pacific Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.4.7.3. Rest of Asia Pacific Plasma Protein Therapeutic Market revenue, by region, 2015 - 2024(USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 7.5.2. Latin America Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
      • 7.5.3. Latin America Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.5.4.2. Brazil Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.5.4.3. Brazil Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.5.5.2. Rest of Latin America Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.5.5.3. Rest of Latin America Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 7.6.2. The Middle East and Africa Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
      • 7.6.3. The Middle East and Africa Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
  •  
  • Chapter 8. Company Profile
    • 8.1. Octapharma
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. CSL Limited
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Baxter
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Telecris
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Grifols
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Kedrion
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Chengdu Inst.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments

List of Figures 

1. Market research process
2. Market research methodology
3. Global Plasma Protein Therapeutic Market revenue, 2015 – 2024 (USD Billion) 
4. Porter’s five forces analysis
5. Plasma Protein Therapeutic Market attractiveness analysis, by Product Type segment
6. Plasma Protein Therapeutic Market attractiveness analysis, by Application segment
7. Plasma Protein Therapeutic Market: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2015 
9. Global Plasma Protein Therapeutic Market revenue share by Product Type, 2015 and 2024
10.  Global Plasma Protein Therapeutic Market, 2015 – 2024 (USD Billion)
a. Global Coagulation Factor Market, 2015 – 2024(USD Billion)
b. Global Immunoglobulin Market, 2015 – 2024(USD Billion)
c. Global Alpha-1 Proteinase Inhibitor Market, 2015 – 2024(USD Billion)
d. Global Albumin Market, 2015 – 2024(USD Billion)
11. Global Plasma Protein Therapeutic Market revenue share by Application, 2015 and 2024
12. Global Plasma Protein Therapeutic Market, 2015 – 2024 (USD Billion)
a. Global Hemophilia Market, 2015 – 2024(USD Billion)
b. Global Primary Immunodeficiency Disorder Market, 2015 – 2024(USD Billion)
c. Global Idiopathic Thrombocytopenic Purpura Market, 2015 – 2024(USD Billion)
d. Global Secondary Immunodeficiency Market, 2015 – 2024(USD Billion)
e. Global Hereditary Angioedema Market, 2015 – 2024(USD Billion)
f. Global Other Indications Market, 2015 – 2024(USD Billion)


List of Tables

1. Plasma Protein Therapeutic Market: Market snapshot                                                            
2. Drivers of global Plasma Protein Therapeutic Market: Impact analysis 
3. Restraints of Plasma Protein Therapeutic Market: Impact analysis 
4. North America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
5. North America Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
6. North America Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
7. The U.S. Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
8. The U.S. Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
9. The U.S. Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
10. Rest of North America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
11. Rest of North America Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
12. Rest of North America Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
13. Europe Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion)
14. Europe Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
15. Europe Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
16. Germany Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion)
17. Germany Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
18. Germany Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
19. U.K. Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
20. U.K. Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
21. U.K. Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
22. France Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
23. France Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
24. France Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
25. Rest of Europe Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion)
26. Rest of Europe Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion)
27. Rest of Europe Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
28. Asia Pacific Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion)
29. Asia Pacific Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion)
30. Asia Pacific Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
31. China Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
32. China Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
33. China Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
34. Japan Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
35. Japan Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
36. Japan Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
37. India Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
38. India Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
39. India Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
40. Rest of Asia Pacific Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion)
41. Rest of Asia Pacific Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion)
42. Rest of Asia Pacific Plasma Protein Therapeutic Market revenue, by region, 2015 – 2024(USD Billion)
43. Latin America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
44. Latin America Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
45. Latin America Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
46. Brazil Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
47. Brazil Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
48. Brazil Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
49. Rest of Latin America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
50. Rest of Latin America Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
51. Rest of Latin America Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion)
52. The Middle East and Africa Plasma Protein Therapeutic Market revenue, by Product Type, 2015 – 2024(USD Billion) 
53. The Middle East and Africa Plasma Protein Therapeutic Market revenue, by Application, 2015 – 2024(USD Billion) 
54. The Middle East and Africa Plasma Protein Therapeutic Market revenue, by Region, 2015 – 2024(USD Billion) 

Methodology

Free Analysis

Plasma is the single largest component made up of 90% of water and has enzymes, salts, antibodies, and other proteins. It can be defined as the clear, straw-colored fluid part of the blood which residue after red platelets, blood cells, white blood cells, and other cellular components are eliminated. Plasma proteins have different functions, including transport of different biochemicals (lipids, hormones, etc.) in the circulatory system; some functions of the plasma protein include blood clotting, fighting against diseases, and other vital functions. Various proteins are present in the plasma of human blood. A blend of simple proteins, lipoproteins, glycoproteins, and other additional conjugated proteins are called as plasma proteins. Plasma protein therapy is an inimitable biological medicine; it has a biochemical profile because of which it differs in processing and production methods and thus is used for the treatment of various genetic, life-threatening chronic and rare diseases.

According to the Plasma Protein Therapeutics Association (PPTA), plasma proteins are used in a variety of rare diseases treatment such as primary immunodeficiency disease, alpha-1 antitrypsin deficiency, and hemophilia A. It can also be used to treat conditions such as shocks & burns, Rh incompatibility, organ transplants, pediatric HIV, trauma, cardiopulmonary issues, liver conditions, and animal bites; they are also used in major surgeries. Hemophilia disease occurs in about 1 of every 5,000 male births, at present about 20,000 males in the U.S are living with the disorder. These plasma proteins play a vital function in clotting and providing immunity against the diseases. 

Global Plasma Protein Therapeutic Market

The major driver for the plasma protein therapeutic market is the growing application of the plasma proteins derivative medicines. Development of novel plasma-derived therapies is another major driver for the growth of this market. Rising prevalence of life-threatening diseases including immune or neurological system such as chronic inflammatory demyelinating polyneuropathy (CIPD), multifocal motor neuropathy (MMN), idiopathic thrombocytopenic purpura (ITP), and other infectious diseases are expected to drive the plasma protein therapeutic market growth. Additionally, modernization in the technologies provided efficient and cost-effective methods for fractionating the proteins from plasma, which is expected to boost the market growth. Implementation of stringent regulatory policies and issues pertaining to reimbursements are likely to inhibit the market’s trajectory. The existing complexity in biologics manufacturing is also expected to create threats for the market.

Based on product type, the plasma protein therapeutic market has been segmented into coagulation factors, immunoglobulin, alpha-1 proteinase inhibitor, and albumin. Based on application, the plasma protein therapeutic market can be divided into hemophilia, primary immunodeficiency disorder, idiopathic thrombocytopenic purpura, secondary immunodeficiency, hereditary angioedema, and other indications (Kawasaki disease, GBS, CIDP). Growing government initiatives, increased awareness among the healthcare practitioners, and growing disposable income of the patients are some of the factors that drive the global market for plasma protein therapeutic.

According to the Plasma Protein Therapy Association (PPTA), North America region gained up to 40% of the market in 2013 and is expected to dominate the plasma protein therapeutic market with the highest amount of blood collection. Europe is the second largest market in the global plasma protein therapeutics market. Due to the increasing awareness about blood donations, Asia Pacific is expected to witness a noteworthy growth for the forecast period. Some of the most lucrative markets for plasma protein therapeutics in Europe include Switzerland, Germany, Spain, Italy, France, Sweden, and the U.K.

Some of the key players in plasma protein therapeutic market include Octapharma, CSL Limited, Baxter, Telecris, Grifols, LFB Group, Kedrion, and Chengdu Inst; Japan Red Cross, Shanghai Blood Institute, BPL Group, and Sanquin are some of the nonprofit organizations which are playing an important role in plasma protein therapeutic market.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social